Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 89Precursor Cell Lymphoblastic Leukemia-Lymphoma 80Leukemia 75Myelodysplastic Syndromes 72Leukemia, Lymphocytic, Chronic, B-Cell 67Lymphoma, Non-Hodgkin 66Multiple Myeloma 58Hodgkin Disease 54Lymphoma, Mantle-Cell 53Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 49Leukemia, Myeloid, Chronic-Phase 48Lymphoma 44Lymphoma, B-Cell, Marginal Zone 43Burkitt Lymphoma 43Myeloproliferative Disorders 41Lymphoma, Large-Cell, Immunoblastic 39Leukemia, Myelomonocytic, Chronic 38Leukemia, Myeloid, Accelerated Phase 38Congenital Abnormalities 37Anemia, Refractory, with Excess of Blasts 33Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Dendritic Cell Sarcoma, Interdigitating 30Blast Crisis 30Recurrence 29Graft vs Host Disease 29Primary Myelofibrosis 25Waldenstrom Macroglobulinemia 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, T-Cell, Cutaneous 22

Interventions

fludarabine 9Cytarabine 9venetoclax 5fludarabine phosphate 5Cyclophosphamide 5Busulfan 5thymoglobulin 4Tacrolimus 4Sirolimus 4Mycophenolic Acid 4Methotrexate 4Azacitidine 4aldesleukin 3Whole-Body Irradiation 3Interleukin-2 3Antilymphocyte Serum 3asciminib 2Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Dasatinib 2Cyclosporine 2Bone Marrow Transplantation 2Blood Specimen Collection 2Behavior Therapy 2zileuton 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myeloid × Cyclosporine × Clear all
NCT00568633 2019-09-24

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Stanford University

Phase 3 Terminated
58 enrolled 18 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡